Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


ELMS STEVE Create: Alert

All | News | Filings
Date FiledTypeDescription
06/08/2023 4 ELMS STEVE (Director) has filed a Form 4 on Marker Therapeutics, Inc.
Txns: Granted 8,000 options to buy @ $1.72, valued at $13.8k
03/08/2023 4 ELMS STEVE (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns: Granted 25,815 shares @ $0
Granted 51,630 options to buy @ $3.35, valued at $173k
06/22/2022 4 Aisling Capital IV, LP (10% Owner) has filed a Form 4 on Elevation Oncology, Inc.
Txns: Granted 15,619 options to buy @ $1.31, valued at $20.5k
05/26/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2021 4 Aisling Capital IV, LP (10% Owner) has filed a Form 4 on Elevation Oncology, Inc.
Txns: Converted 1,893,232 shares @ $0
Converted 458,360 shares @ $0
Bought 187,500 shares @ $16, valued at $3M
Converted 8,000,000 preferred shares @ $0
Converted 1,936,834 preferred shares @ $0
06/28/2021 4 Aisling Capital IV, LP (10% Owner) has filed a Form 4 on Elevation Oncology, Inc.
Txns: Granted 31,238 options to buy @ $16, valued at $499.8k
06/24/2021 3 Aisling Capital IV, LP (10% Owner) has filed a Form 3 on Elevation Oncology, Inc.
06/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/05/2020 4 ELMS STEVE (Director) has filed a Form 4 on Zosano Pharma Corp
Txns: Granted 15,000 options to buy @ $1.01, valued at $15.2k
05/01/2020 4/A ELMS STEVE (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns: Granted 7,500 shares @ $0
03/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/06/2019 4 Aisling Capital IV, LP (10% Owner) has filed a Form 4 on Zosano Pharma Corp
Txns: Granted 689,655 shares @ $1.45, valued at $1000k
08/08/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/08/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
07/18/2019 4 ELMS STEVE (10% Owner) has filed a Form 4 on Zosano Pharma Corp
Txns: Granted 1,500 options to buy @ $2.34, valued at $3.5k
07/15/2019 4 Aisling Capital IV, LP (10% Owner) has filed a Form 4 on SUNESIS PHARMACEUTICALS INC
Txns: Bought 2,500,000 shares @ $0.6, valued at $1.5M
04/12/2019 4 Aisling Capital IV, LP (10% Owner) has filed a Form 4 on Zosano Pharma Corp
Txns: Granted 428,571 shares @ $3.5, valued at $1.5M
03/15/2019 4 ELMS STEVE (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns: Granted 30,000 options to buy @ $3.89, valued at $116.7k
02/15/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/24/2019 3 Aisling Capital IV, LP (10% Owner) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC
07/12/2018 4 AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 1,400,000 shares @ $179.43, valued at $251.2M
06/25/2018 4 ELMS STEVE (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns: Granted 17,500 options to buy @ $4.91, valued at $85.9k
06/14/2018 4 ELMS STEVE (10% Owner) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Granted 8,750 options to buy @ $180.98, valued at $1.6M
05/21/2018 4 ELMS STEVE (10% Owner) has filed a Form 4 on Zosano Pharma Corp
Txns: Granted 25,000 options to buy @ $4.27, valued at $106.8k
04/12/2018 3/A Aisling Capital IV, LP (10% Owner) has filed a Form 3/A on Zosano Pharma Corp
04/09/2018 3 Aisling Capital IV, LP (10% Owner) has filed a Form 3 on Zosano Pharma Corp
12/20/2017 4 AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 250,000 shares @ $80.5, valued at $20.1M
11/27/2017 4 AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 500,000 shares @ $75, valued at $37.5M
06/23/2017 4 ELMS STEVE (10% Owner) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Granted 11,000 options to buy @ $78.58, valued at $864.4k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy